The Living Guidelines: STEMI Thienopyridines Polling Results for CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIa Guidelines
1- In patients <75 years of age who receive fibrinolytic therapy or who do not receive reperfusion therapy, it is reasonable to administer an oral loading dose of clopidogrel 300 mg. (Class IIa, Level of Evidence: C) (No data are available to guide decision making regarding an oral loading dose in patients 75 years of age or older).

 AHA / ACC 2007 STEMI Guidelines for Thienopyridines Therapy Class IIa Recommendation 1 should be: CLASS I CLASS IIa CLASS IIb CLASS III

2- Long-term maintenance therapy (e.g., 1 year) with clopidogrel (75 mg / day orally) is reasonable in STEMI patients regardless of whether they undergo reperfusion with fibrinolytic therapy or do not receive reperfusion therapy. (Class IIa Level of Evidence: C)

 AHA / ACC 2007 STEMI Guidelines for Thienopyridines Therapy Class IIa Recommendation 2 should be: CLASS I CLASS IIa CLASS IIb CLASS III